GlassScriptPhysician profile
Leonard A Merlo
NPI 1346245198
$4,728.56
in general payments reported to CMS, 2019-2025
10 companies · $1,988 in 2025
The $1,988 reported for 2025 was more than what 92% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $136 · 2021: $277 · 2022: $142 · 2023: $538 · 2024: $891 · 2025: $1,988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,048 · Travel and Lodging: $1,351 · Education: $17.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,048.46 |
| Travel and Lodging | $1,351.41 |
| Education | $17.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $2,359.44 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $2,094.52 | 2019-2025 | Traumaone, Neuro Plating System, Omnimax |
| Ace Surgical Supply Co., INC. | $84.37 | 2020-2022 | |
| Straumann USA LLC | $60.47 | 2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $32.12 | 2024-2025 | Ossix Plus, Arestin |
| Biohorizons Implant Systems INC. | $30.59 | 2020 | |
| Depuy Synthes Sales INC. | $19.39 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.33 | 2025 | Exparel |
| Henry Schein, INC. | $15.39 | 2025 | Nuoss, Ace Surgical Supply, Allooss Allograft Putty |
| Southern Implants North America INC | $13.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Merlo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.